Types of Pharmacy Audits and Who Runs Each One

A pharmacy that receives an audit notice does not always know, from the letter alone, which authority is behind it. A PBM audit, a Medicare Part D plan or contractor review, a state Medicaid program integrity audit, a DEA inspection, a state board of pharmacy inspection, and a manufacturer or REMS audit each run on a different authority and put a different asset at risk, from money to the pharmacy's ability to dispense controlled substances. Identifying which one arrived is the first step in responding to it.

PBM Audits

A PBM audit is run by the pharmacy benefit manager itself, or by a third-party auditor the PBM retains and pays to review claims. The rules come from the PBM's own provider manual. For what the process looks like at two specific PBMs, see MedImpact Audit Findings: How Pharmacies Respond and Navitus Audits: What Pharmacies Should Know. A finding becomes a recoupment demand, and a pattern of findings can lead to network termination. Disputes go first to the PBM's own internal review, the stage known as the audit appeal, before any outside forum opens.

Medicare Part D and State Medicaid Reviews

A Medicare Part D audit starts with the plan sponsor, or with the PBM the plan has delegated pharmacy audits to. CMS separately retains its own national contractor, the Medicare Drug Integrity Contractor (MEDIC), to investigate suspected fraud, waste, and abuse across Part D plans, not to run routine claim reviews. A state Medicaid program integrity audit is run by the state Medicaid agency's own program integrity unit, which handles administrative overpayment recovery. That unit is separate from the state's Medicaid Fraud Control Unit (MFCU), usually an office under the state attorney general that investigates and prosecutes Medicaid fraud. A Part D finding can mean recoupment and removal from the plan sponsor's pharmacy network. A state Medicaid finding can mean recoupment from the state program, and a referral from the program integrity unit can bring the MFCU into the matter. Part D disputes go through the plan sponsor's own appeal process. A Medicaid finding is contested through the state agency's administrative review before any court gets involved.

DEA and Board of Pharmacy Inspections

A DEA inspection is conducted by DEA diversion investigators, who check a pharmacy's controlled substance recordkeeping and security against the Controlled Substances Act. Findings can lead to an order to show cause seeking to suspend or revoke the pharmacy's DEA registration, which ends the pharmacy's ability to handle controlled substances, not a recoupment demand. Requesting a hearing puts the matter before a DEA administrative law judge, not a court. A state board of pharmacy inspection reaches the pharmacist's or the pharmacy's state license instead, run by the board's own compliance staff under state pharmacy law. A board's disciplinary options can range from a reprimand to revocation of the license, the span the Texas State Board of Pharmacy describes for its own cases, with disputes heard first in the board's own administrative hearing and further appeal available under state law.

Manufacturer and REMS Audits

A manufacturer or REMS audit is run by the drug manufacturer or by a REMS program administrator it has retained, checking compliance with the FDA-approved REMS for that drug. FDA oversees the REMS program itself and can audit pharmacy compliance directly as well. The audit puts the pharmacy's part in the REMS program at risk rather than its claim reimbursement: a pharmacy whose registration is revoked must stop dispensing that drug.

A pharmacy audit notice does not name the authority behind it in plain terms, and the response that defeats a PBM audit will not defeat a DEA inspection.

Why Early Legal Counsel Is Critical

It is critical that pharmacies promptly retain experienced healthcare defense counsel upon receiving any of these notices, a PBM audit, a Medicare Part D review, a state Medicaid audit, a DEA inspection, a board of pharmacy inspection, or a manufacturer REMS audit alike. Early legal intervention can protect the pharmacy's rights, shape the response before a sample finding hardens into a demand or a show cause order, avoid inadvertent admissions during the records exchange, and allow counsel to communicate with the auditor on the pharmacy's behalf. Delaying representation can narrow the pharmacy's options once the auditor has already drawn its conclusions, and the exposure compounds for pharmacies covered in Multi-Location Pharmacy Groups: Audit Exposure Across Stores.

How Health Law Alliance Can Help

Health Law Alliance has represented 2,500+ clients nationwide. If your pharmacy has received an audit or inspection notice and is not certain which authority sent it, contact Health Law Alliance's PBM audit defense attorneys for a free, confidential consultation before any response deadline passes.